REX LARGEN: Open Payments
NPI 1326036112 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,885 in 240 payments from 21 companies in 2025. Trend: 2023 $4,001 · 2024 $4,049 · 2025 $5,885
Food & beverage: $4,441Consulting: $1,300Education: $144
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $1,852 |
| ABBVIE INC. | 27 | $575 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $452 |
| Lilly USA, LLC | 17 | $381 |
| GENZYME CORPORATION | 13 | $309 |
| Janssen Biotech, Inc. | 16 | $293 |
| Novartis Pharmaceuticals Corporation | 15 | $248 |
| LEO Pharma Inc. | 12 | $228 |
| Regeneron Healthcare Solutions, Inc. | 8 | $221 |
| PFIZER INC. | 21 | $205 |
Products named: Bimzelx, DUPIXENT, TALTZ, SKYRIZI, TREMFYA, RINVOQ, ILUMYA, Sotyktu.
Industry payments across NE — which companies pay providers there.
